95 related articles for article (PubMed ID: 2247485)
21. [Adjuvant therapy also in node-negative breast cancer?].
Barth JA
Zentralbl Gynakol; 1990; 112(2):57-9. PubMed ID: 2316296
[No Abstract] [Full Text] [Related]
22. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
Rosso R; Boccardo F; Brema F; Sertoli MR; Amoroso D; Bertelli G; Pronzato P
Anticancer Res; 1989; 9(4):1153-6. PubMed ID: 2817796
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant systemic therapy of breast cancer.
Lippman ME
Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
[No Abstract] [Full Text] [Related]
24. [Improvement of survival due to adjuvant therapy in patients with operable breast carcinoma].
Repelaer van Driel OJ; Welvaart K; Stijnen T
Ned Tijdschr Geneeskd; 1986 Apr; 130(16):744-6. PubMed ID: 3713882
[No Abstract] [Full Text] [Related]
25. [New approaches in adjuvant chemotherapy of breast cancer].
Salzer H; Sevelda P
Gynakol Rundsch; 1988; 28(2):123-5. PubMed ID: 3402824
[No Abstract] [Full Text] [Related]
26. Mastectomy followed by cytoreductive chemotherapy in locally advanced breast cancer.
Pluzańska A; Berner J; Dowgier-Witczak I; Malecka E; Pawlowski R; Wrezel E; Jeziorski A; Kamińska A; Tenderenda M
J Chemother; 1989 Jul; 1(4 Suppl):1186-8. PubMed ID: 16312827
[No Abstract] [Full Text] [Related]
27. Adjuvant therapy in breast cancer.
Robert NJ
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
[TBL] [Abstract][Full Text] [Related]
28. [Neoadjuvant chemotherapy of patients with breast carcinoma].
Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant treatment in breast cancer. II.
García-Conde DJ
Chemioterapia; 1987 Jun; 6(2 Suppl):711. PubMed ID: 3509527
[No Abstract] [Full Text] [Related]
30. Side-effects of pre-operative epirubicin-paclitaxel therapy in primary breast cancer associated with tumor biology.
Warm M; Kates R; Thomas A; Fischer T; Harbeck N
Anticancer Res; 2009 Jul; 29(7):2675-80. PubMed ID: 19596945
[TBL] [Abstract][Full Text] [Related]
31. When is adjuvant treatment of stage IIIA breast cancer recommended?
Siemers R
Oncology (Williston Park); 1987 Dec; 1(10):39. PubMed ID: 3275339
[No Abstract] [Full Text] [Related]
32. [High-dose chemotherapy with hematopoietic stem-cell support in breast cancer].
Viens P; Maraninchi D
Bull Cancer; 2001 Sep; 88(9):835-41. PubMed ID: 11604355
[No Abstract] [Full Text] [Related]
33. Biology of residual breast cancer after therapy: a kinetic interpretation.
Norton L
Prog Clin Biol Res; 1990; 354A():109-32. PubMed ID: 2247484
[No Abstract] [Full Text] [Related]
34. Adjuvant chemotherapy in breast cancer.
Langlands AO; Tiver KW
Int J Radiat Oncol Biol Phys; 1984 Jun; 10(6):943-4. PubMed ID: 6735780
[No Abstract] [Full Text] [Related]
35. Surgery-induced immunomodulation in breast cancer.
Chen XB; Fang XD; Zhang HL
J Surg Oncol; 2011 Feb; 103(2):197; author reply 196. PubMed ID: 21259258
[No Abstract] [Full Text] [Related]
36. High-dose adjuvant chemotherapy for high-risk breast cancer.
Abeloff MD
Recent Results Cancer Res; 1993; 127():177-83. PubMed ID: 8502814
[No Abstract] [Full Text] [Related]
37. Adjuvant chemotherapy. Eight years later.
Costanza ME
JAMA; 1984 Nov; 252(18):2611-2. PubMed ID: 6492345
[No Abstract] [Full Text] [Related]
38. Kinetic concepts in the treatment of breast cancer.
Norton L
Recent Results Cancer Res; 1993; 127():1-6. PubMed ID: 8502805
[No Abstract] [Full Text] [Related]
39. Psychological factors in immunomodulation induced by cancer surgery: a review.
Garssen B; Boomsma MF; Beelen RH
Biol Psychol; 2010 Sep; 85(1):1-13. PubMed ID: 20576501
[TBL] [Abstract][Full Text] [Related]
40. Salvage therapy in advanced breast cancer.
Paridaens RJ
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1443-7. PubMed ID: 3830725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
